Angela Bilkhu joined Roche Canada in 2018 where she was a Senior Manager with the Federal Government Relations and Policy Team. She focused on delivering innovative strategies and plans that established a favourable policy environment for Roche’s pipeline specialty molecules. In this role, Angela worked to support policy and access priorities in rare diseases, oncology and neurosciences, building meaningful relationships with key stakeholders, including patients, caregivers and patient organizations to embed their voice into Roche Canada’s policy strategies and tools. In 2020, Angela joined the Global Patient Partnership Team to assume a newly created role focussed on patient-centric research and development activities in the solid tumour space. Angela worked closely with Roche-Genentech’s Product Development teams and the patient community to ensure Roche’s research and development activities are patient inclusive. In her free time, Angela loves to spend time with her husband, daughter and son travelling the world taking cooking classes so she can bring a little bit of each adventure back into their home.
